16. We recommend endovascular procedures over open surgery for focal occlusive disease of the SFA artery not involving the origin at the femoral bifurcation (Grade 1, Level C).
17. For focal lesions (<5 cm) in the SFA that have unsatisfactory technical results with balloon angioplasty, we suggest selective stenting (Grade 2, Level C).
18. For intermediate-length lesions (5-15 cm) in the SFA, we recommend the adjunctive use of selfexpanding nitinol stents (with or without paclitaxel) to improve the midterm patency of angioplasty (Grade 1, Level B).
19. We suggest the use of preoperative ultrasound vein mapping to establish the availability and quality of autogenous vein conduit in patients being considered for infrainguinal bypass for the treatment of IC (Grade 2, Level C).
20. We recommend against EVT of isolated infrapopliteal disease for IC because this treatment is of unproven benefit and possibly harmful (Grade 1, Level C).
21. We recommend surgical bypass as an initial revascularization strategy for patients with diffuse FP disease, small caliber (<5 mm), or extensive calcification of the SFA, if they have favorable anatomy for bypass (popliteal artery target, good runoff) and have average or low operative risk (Grade 1, Level B).
22. We recommend using the saphenous vein as the preferred conduit for infrainguinal bypass grafts (Grade 1, Level A).
23. In the absence of suitable vein,we suggest using prosthetic conduit forFPbypass in claudicant patients, if the above-knee popliteal artery is the target vessel and good runoff is present (Grade 2, Level C).

EVT, Endovascular therapy; SFA, superficial femoral artery.